Is the use of Ro 10-9359 (Tigason) in children justified?
DOI:
https://doi.org/10.2340/0001555560274275Abstract
In 5 children ranging in age from 8 to 12 years, treatment with Ro 10-9359 for either psoriasis or erythrokeratodermia variabilis for periods of between 11 and 17 months did not cause marked growth retardation and gave excellent therapeutic results.Downloads
Download data is not yet available.
Downloads
Published
1980-05-05
How to Cite
van der Rhee, H., van Gelderen, H., & Polano, M. (1980). Is the use of Ro 10-9359 (Tigason) in children justified?. Acta Dermato-Venereologica, 60(3), 274–275. https://doi.org/10.2340/0001555560274275
Issue
Section
Articles
License
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
